相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Agonists and inhibitors of the STING pathway: Potential agents for immunotherapy
Jun-Jun Wu et al.
MEDICINAL RESEARCH REVIEWS (2020)
Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity
Ji Wang et al.
SCIENCE (2020)
Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma
Lihong Wang-Bishop et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Employing bicontinuous-to-micellar transitions in nanostructure morphology for on-demand photo-oxidation responsive cytosolic delivery and off-on cytotoxicity
Sharan Bobbala et al.
NANOSCALE (2020)
Trojan horses for immunotherapy
Jeffrey A. Hubbell et al.
NATURE NANOTECHNOLOGY (2019)
Pharmacological Modulation of the STING Pathway for Cancer Immunotherapy
Gilles Berger et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Viromimetic STING Agonist-Loaded Hollow Polymeric Nanoparticles for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus
Leon Chien-Wei Lin et al.
ADVANCED FUNCTIONAL MATERIALS (2019)
STING pathway agonism as a cancer therapeutic
Blake A. Flood et al.
IMMUNOLOGICAL REVIEWS (2019)
Pharmacological modulation of nucleic acid sensors - therapeutic potential and persisting obstacles
Claire Vanpouille-Box et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases
Yang Liu et al.
NATURE COMMUNICATIONS (2019)
Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
Daniel Shae et al.
NATURE NANOTECHNOLOGY (2019)
The efficiency of cytosolic drug delivery using pH-responsive endosomolytic polymers does not correlate with activation of the NLRP3 inflammasome
Jessalyn J. Baljon et al.
BIOMATERIALS SCIENCE (2019)
The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells
Alice Gutjahr et al.
JCI INSIGHT (2019)
Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy
David R. Wilson et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Role of the cGAS-STING pathway in cancer development and oncotherapeutic approaches
Li Teng Khoo et al.
EMBO REPORTS (2018)
Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists
Michael A. Collier et al.
MOLECULAR PHARMACEUTICS (2018)
Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity
Kelsey E. Sivick et al.
CELL REPORTS (2018)
Enhancing immunotherapy of STING agonist for lymphoma in preclinical models
Adrienne Sallets et al.
BLOOD ADVANCES (2018)
A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer
Ning Cheng et al.
JCI INSIGHT (2018)
cGAS is essential for the antitumor effect of immune checkpoint blockade
Hua Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Liposomal Delivery Enhances Immune Activation by STING Agonists for Cancer Immunotherapy
Sandeep T. Koshy et al.
ADVANCED BIOSYSTEMS (2017)
The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons
Elizabeth. C. Carroll et al.
IMMUNITY (2016)
The host STING pathway at the interface of cancer and immunity
Leticia Corrales et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing
Qi Chen et al.
NATURE IMMUNOLOGY (2016)
Established T Cell-Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade
Ellen Moore et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Nanoparticu late STING agonists are potent lymph node-targeted vaccine adjuvants
Melissa C. Hanson et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma
Takashi Nakamura et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Intracellular Delivery System for Antibody-Peptide Drug Conjugates
Geoffrey Y. Berguig et al.
MOLECULAR THERAPY (2015)
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
Leticia Corrales et al.
CELL REPORTS (2015)
Overcoming transport barriers for interstitial-, lymphatic-, and lymph node-targeted drug delivery
Susan N. Thomas et al.
CURRENT OPINION IN CHEMICAL ENGINEERING (2015)
Balancing Cationic and Hydrophobic Content of PEGylated siRNA Polyplexes Enhances Endosome Escape, Stability, Blood Circulation Time, and Bioactivity in Vivo
Christopher E. Nelson et al.
ACS NANO (2013)
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
Hiroshi Maeda et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Pivotal Roles of cGAS-cGAMP Signaling in Antiviral Defense and Immune Adjuvant Effects
Xiao-Dong Li et al.
SCIENCE (2013)
Diblock copolymers with tunable pH transitions for gene delivery
Matthew J. Manganiello et al.
BIOMATERIALS (2012)
Self-assembly of block copolymers
Yiyong Mai et al.
CHEMICAL SOCIETY REVIEWS (2012)
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles
Catarina Pinto Reis et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2006)
分享论文
